Skip to main content
Jagsonpal Pharmaceuticals Limited logo

Jagsonpal Pharmaceuticals Limited — Investor Relations & Filings

Ticker · JAGSNPHARM ISIN · INE048B01035 BSE.NS Manufacturing
Filings indexed 1,041 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country IN India
Listing BSE.NS JAGSNPHARM

About Jagsonpal Pharmaceuticals Limited

https://www.jagsonpal.com/

Jagsonpal Pharmaceuticals Limited specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company maintains a significant focus on therapeutic segments including gynecology, orthopedics, and pain management. Its product portfolio features established brands in women's healthcare, particularly in the areas of pregnancy care and hormonal therapy, as well as treatments for bone health and inflammatory conditions. The organization leverages its research and development capabilities to introduce specialized formulations that address specific medical needs in its core therapeutic areas. By maintaining an extensive distribution network, the company ensures the accessibility of its products to healthcare professionals and patients, focusing on quality and therapeutic efficacy across its specialized product lines.

Recent filings

Filing Released Lang Actions
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-18 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-18 English
Resignation
Board/Management Information Classification · 95% confidence The document is an intimation under SEBI LODR Regulation 30 regarding the resignation of an Independent Director, including details of cessation, disclosures under Schedule III, and enclosures of resignation letters. This clearly constitutes an announcement of a change in the company’s board composition, fitting the Board/Management Information category.
2026-05-18 English
Resignation of an Independent Director.
Board/Management Information Classification · 93% confidence The document is an intimation under SEBI LODR Regulation 30 informing the stock exchanges of the resignation of an Independent Director, including disclosure annexures and the director’s resignation letter. This is a classic announcement of a board change, namely a director’s resignation. Therefore it falls under the Board/Management Information category.
2026-05-18 English
Copy of Newspaper Publication
Regulatory Filings
2026-05-07 English
Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company
Transaction in Own Shares Classification · 84% confidence The document is a formal notice filed with BSE and NSE regarding the publication of a buyback offer opening advertisement in newspapers, confirming timelines and dispatch of the Letter of Offer for the company’s share buyback. This is a Share Repurchase announcement, fitting the “Transaction in Own Shares” category (POS).
2026-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.